CAMP4 THERAPEUTICS Valuation
| CAMP Stock | USD 5.41 0.37 6.40% |
At this time, the entity appears to be overvalued. CAMP4 THERAPEUTICS shows a prevailing Real Value of $4.65 per share. The current price of the entity is $5.41. Our model approximates the value of CAMP4 THERAPEUTICS from examining the entity fundamentals such as EBITDA of (8.72 M), total debt of 178.68 M, and Net Income of (49.29 M) as well as evaluating its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that CAMP4 THERAPEUTICS's price fluctuation is very risky at this time. Calculation of the real value of CAMP4 THERAPEUTICS is based on 3 months time horizon. Increasing CAMP4 THERAPEUTICS's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
CAMP4 THERAPEUTICS's intrinsic value may or may not be the same as its current market price of 5.41, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.41 | Real 4.65 | Hype 5.01 | Naive 6.11 |
The intrinsic value of CAMP4 THERAPEUTICS's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence CAMP4 THERAPEUTICS's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of CAMP4 THERAPEUTICS PORATION helps investors to forecast how CAMP4 stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CAMP4 THERAPEUTICS more accurately as focusing exclusively on CAMP4 THERAPEUTICS's fundamentals will not take into account other important factors: CAMP4 THERAPEUTICS Total Value Analysis
CAMP4 THERAPEUTICS PORATION is currently expected to have valuation of 0 with market capitalization of 660.34 K, debt of 178.68 M, and cash on hands of 47.72 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the CAMP4 THERAPEUTICS fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 660.34 K | 178.68 M | 47.72 M |
CAMP4 THERAPEUTICS Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of CAMP4 connotes not a very effective usage of assets in November.CAMP4 THERAPEUTICS Profitability Analysis
The company reported the previous year's revenue of 186.23 M. Net Loss for the year was (49.29 M) with profit before overhead, payroll, taxes, and interest of 0.About CAMP4 THERAPEUTICS Valuation
The stock valuation mechanism determines CAMP4 THERAPEUTICS's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of CAMP4 THERAPEUTICS based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of CAMP4 THERAPEUTICS. We calculate exposure to CAMP4 THERAPEUTICS's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CAMP4 THERAPEUTICS's related companies.CalAmp Corp., a connected intelligence company, provides leverages a data-driven solutions ecosystem to people and organizations in the United States, Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and internationally. The company was incorporated in 1981 and is headquartered in Irvine, California. CalAmp Corp operates under Communication Equipment classification in the United States and is traded on NASDAQ Exchange. It employs 887 people.
CAMP4 THERAPEUTICS Growth Indicators
Investing in growth stocks can be very risky. If the company such as CAMP4 THERAPEUTICS does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 37 M |
Additional Tools for CAMP4 Stock Analysis
When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.